ETFA Gene Acyl-CoA multiple dehydrogenase deficiency Genetic Test
Are you concerned about Acyl-CoA multiple dehydrogenase deficiency? DNA Labs UAE offers the ETFA Gene Acyl-CoA multiple dehydrogenase deficiency Genetic Test to provide you with valuable insights into this rare genetic disorder.
Test Components
- Price: 3200.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Metabolic Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Prior to undergoing the ETFA Gene Acyl-CoA multiple dehydrogenase deficiency NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with Acyl-CoA multiple dehydrogenase deficiency.
Test Details
ETFA Gene Acyl-CoA multiple dehydrogenase deficiency is a rare genetic disorder that affects the metabolism of fats and proteins. This disorder is caused by mutations in the ETFA gene, which provides instructions for making an enzyme called electron transfer flavoprotein alpha subunit. The enzyme is involved in the process of fatty acid oxidation, which breaks down fats and proteins for energy production.
The NGS Genetic Test, also known as Next-Generation Sequencing Genetic Test, is a cutting-edge genetic testing method that allows for the simultaneous analysis of multiple genes. By using advanced sequencing technologies, this test can detect mutations or variations in the DNA sequence associated with genetic disorders, including ETFA Gene Acyl-CoA multiple dehydrogenase deficiency.
The ETFA Gene Acyl-CoA multiple dehydrogenase deficiency NGS Genetic Test involves obtaining a DNA sample, usually through a blood sample or a cheek swab. The DNA is then sequenced using next-generation sequencing technology, which can rapidly and accurately analyze the entire coding region of the ETFA gene. The sequencing data is analyzed and compared to a reference sequence to identify any genetic variations or mutations.
The results of the NGS Genetic Test provide valuable information about the presence of mutations in the ETFA gene, confirming a diagnosis of Acyl-CoA multiple dehydrogenase deficiency. Additionally, the specific mutations identified can be useful for genetic counseling and family planning.
It is important to note that genetic testing, including the NGS Genetic Test, should be performed and interpreted by qualified healthcare professionals with expertise in genetics. These professionals can provide appropriate counseling and guidance based on the individual’s test results.
Test Name | ETFA Gene Acyl-CoA multiple dehydrogenase deficiency Genetic Test |
---|---|
Components | |
Price | 3200.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ETFA Gene Acyl-CoA multiple dehydrogenase deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Acyl-CoA multiple dehydrogenase deficiency |
Test Details |
ETFA Gene Acyl-CoA multiple dehydrogenase deficiency is a rare genetic disorder that affects the metabolism of fats and proteins. It is caused by mutations in the ETFA gene, which provides instructions for making an enzyme called electron transfer flavoprotein alpha subunit. This enzyme is involved in a process called fatty acid oxidation, which breaks down fats and proteins for energy production. NGS Genetic Test, also known as Next-Generation Sequencing Genetic Test, is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. It allows for the detection of mutations or variations in the DNA sequence that may be associated with genetic disorders, including ETFA Gene Acyl-CoA multiple dehydrogenase deficiency. The NGS Genetic Test for ETFA Gene Acyl-CoA multiple dehydrogenase deficiency involves obtaining a DNA sample, usually through a blood sample or a cheek swab. The DNA is then sequenced using next-generation sequencing technology, which can rapidly and accurately analyze the entire coding region of the ETFA gene. The sequencing data is then analyzed and compared to a reference sequence to identify any genetic variations or mutations. The results of the NGS Genetic Test can provide valuable information about the presence of mutations in the ETFA gene, which can help confirm a diagnosis of Acyl-CoA multiple dehydrogenase deficiency. It can also provide information about the specific mutations identified, which can be useful for genetic counseling and family planning. It is important to note that genetic testing, including NGS Genetic Test, should be performed and interpreted by qualified healthcare professionals with expertise in genetics. They can provide appropriate counseling and guidance based on the individual’s test results. |